van Dijk Marcus Antonius 4
4 · MiNK Therapeutics, Inc. · Filed Jan 25, 2022
Insider Transaction Report
Form 4
van Dijk Marcus Antonius
Chief Technology Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-21+62,500→ 62,500 totalExercise: $3.12Exp: 2032-01-21→ Common Stock (62,500 underlying)
Footnotes (1)
- [F1]Represents an option to purchase shares of the common stock, which vests as to 35% of the underlying shares on January 21, 2025 and as to the remaining 65% of the underlying shares on January 21, 2026; provided that the Reporting Person maintains a business relationship with the Issuer through each such vesting date.